The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Spiolto Respimat 2.5 microgram/2.5 microgram, inhalation solution

2.5 µg/2.5 microgram(s) Inhalation solution

Boehringer Ingelheim International GmbHPA0775/009/001

Main Information

Trade NameSpiolto Respimat 2.5 microgram/2.5 microgram, inhalation solution
Active SubstancesTiotropium
Strength2.5 µg/2.5 microgram(s)
Dosage FormInhalation solution
Licence HolderBoehringer Ingelheim International GmbH
Licence NumberPA0775/009/001

Group Information

ATC CodeR03BB Anticholinergics
R03BB54 Anticholinergics


Licence Issued19/06/2015
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back